Skip to content

Effect of Whole Body Vibration With Weighted Vest on Motor Function in Children With Spastic Diplegia

Effect of Whole Body Vibration With Weighted Vest on Motor Function in Children With Spastic Diplegia

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05606926
Enrollment
30
Registered
2022-11-07
Start date
2023-01-01
Completion date
2024-11-30
Last updated
2022-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy

Keywords

Cerebral palsy, balance, muscle strength, spastic diplegia, HUMAC balance system

Brief summary

Whole body vibration has been widely used in rehabilitation of individuals with disabilities as well as children with cerebral palsy. Previous studies have demonstrated the efficacy of Whole body vibration on balance, gross motor function, spasticity and bone density in children with cerebral palsy. However, adding extra weight during Whole body vibration for children with cerebral palsy as a means of enhancing the potential effects of Whole body vibration is unknown. Therefore, the aim of this study is to examine the effect of Whole body vibration with weighted vest on trunk control, balance and gross motor function in children with spastic diplegia.

Interventions

OTHERphysical therapy program

Flexibility exercises to restore joint mobility of soft tissues, Static and dynamic balance exercises, Functional gait training , Functional strengthening exercises will be conducted three times a week, for three consecutive months.

OTHERwhole body vibration (without extra weight vest)

9 minutes of three sets of 3-min semi-squats on the vibration platform. three times a week, for three consecutive months.

OTHERwhole body vibration (with weight vest)

The extra-weight applied in the vest will be calculated as 10% of the child body weight. The vest is designed to allow small bags of sand with different weights that are distributed equally on anterior-posterior and mediolateral plans.

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
8 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* Their age will range from 8-12 years, from both sexes. * Level II and III of gross motor functional classification system * Grade 1 and 1+ spasticity according to the Modified Ashworth Scale * Ability to understand and follow simple verbal instruc

Exclusion criteria

* Uncontrolled epilepsy. * Mental retardation or autistic features. * Medication changes that could affect muscle strength or tone * Significant visual or auditory problems according to medical reports (audio-vestibular and ophthalmic examination), * Structural or fixed soft tissue deformities of the lower and/or upper extremities. * Neurological or orthopedic surgery in the past 12 months in the lower and/or upper extremities. * Botox injection in the lower and/or upper extremities in the past 6 months.

Design outcomes

Primary

MeasureTime frameDescription
Trunk controlthree monthsThe Trunk Control Measurement Scale is used to assess trunk control and consists of static and dynamic sitting balance in children aged 8 to 15 years with spastic CP
Gross motor functionthree monthsThe Gross motor function measure-88 will be used to assess motor function in 88 items across five dimensions: (a) lying and rolling, (b) sitting, (c) crawling and kneeling, (d) standing, and (e) walking, running and jumping. dimensions D and E will be assessed in the current study The assessment of each item will be conducted carefully and scored according to the scale scoring key (scale from 0-3) with total score 100 and higher score represent better performance
balancethree monthsHuman computer balance system will be used to assess balance to assess center op pressure and limits of stability

Contacts

Primary ContactAmira M Abd-elmonem, PhD
Dramira.salim2020@gmail.com01155553316

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026